Sign in to view content

FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

Ivan J. Suner, MD, MBA

Video
Published 2019

Ivan J. Suner, MD, MBA

AMD Neovascular Part II Symposium

Related

Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
Diana V Do, MD, FASRS
Annual Meeting Talks
2019
Episode 32 - Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
Predictors of Post-injection Endophthalmitis: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength
Tarek S. Hassan, MD, FASRS
Updates from the Field
2019

Category: AMD-Neovascular

See more